Opportunity Information: Apply for RFA HL 10 021
Apply for RFA HL 10 021
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Innovators in Hemoglobinopathies Academic Career Development Award (K07)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.839 Blood Diseases and Resources Research.
- This funding opportunity was created on Jun 29, 2010 and posted on Jun 29, 2010.
- Applicants must submit their applications by Sep 14, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,484,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $414,000.00 in funding.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) .
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Innovators in Hemoglobinopathies Academic Career Development Award (K07) is a National Heart, Lung, and Blood Institute (NHLBI) grant opportunity designed to help clinician scientists build a long-term research career focused on sickle cell disease and/or thalassemias. Its central aim is career development: it provides up to four years of support to cover both salary and research-related costs for individuals who hold medical or doctoral degrees in clinical fields and who are not yet fully established as independent investigators. The program is especially intended for clinicians who have already demonstrated innovation through patient-focused programs or clinical initiatives in hemoglobinopathies, but who have not previously been on a traditional, formal research track.
A key feature of this award is that it targets a specific gap in the usual NIH career development pipeline. The announcement explicitly notes that it is meant for clinician scientists who would not be eligible for other common NHLBI mentored career development awards such as the K23, K01, K08, or K25. In other words, it is set up to bring strong, practice-informed clinical innovators into research careers even if their background does not fit the typical profiles those other K mechanisms are built around. NHLBI also encourages prospective applicants to communicate directly with institute staff to clarify program fit and budget questions before applying.
The funding mechanism used is the NIH K07 award. Recipients must make a substantial time commitment to the award activities, with a minimum effort requirement of nine person-months per year, which is 75 percent of full-time professional effort. That requirement signals that the award is meant to provide protected time so the candidate can focus heavily on developing research skills, producing publishable work, and building a foundation for future independent funding in hemoglobinopathy research.
In terms of available funding and expected awards, NHLBI planned to commit an estimated total of $2,484,000 in FY2011 to support projects under this solicitation. The institute anticipated making about six awards, and projected total spending of $9,936,000 across the full four-year project periods for those grants. The listed award ceiling is $414,000, indicating the maximum budget level per award under the announcement.
Administratively, this opportunity is a discretionary grant in the health funding category and is associated with CFDA number 93.839 (Blood Diseases and Resources). It does not require cost sharing or matching. The funding opportunity number is RFA-HL-10-021, and it was posted June 29, 2010, with an original and current closing date of September 14, 2010, and an archive date of October 15, 2010. The sponsoring agency is the National Institutes of Health, with NHLBI as the institute issuing the announcement.
Eligible applicant organizations include a wide range of institutional types across the public, private, nonprofit, and for-profit spectrum (excluding small businesses in the listed categories). Specifically included are public and state-controlled institutions of higher education, private institutions of higher education, nonprofits with and without 501(c)(3) status (including those other than institutions of higher education), and for-profit organizations other than small businesses. The eligibility information also highlights inclusion of institutions that serve historically underrepresented populations, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), and Alaska Native and Native Hawaiian-serving institutions. The full announcement was hosted through the NIH grants guide, and NIH provided standard webmaster contacts for access or linking issues.
Frequently Asked Questions (FAQs): Innovators in Hemoglobinopathies Academic Career Development Award (K07)
1. What is the Innovators in Hemoglobinopathies Academic Career Development Award (K07)?
The Innovators in Hemoglobinopathies Academic Career Development Award (K07) is a National Heart, Lung, and Blood Institute (NHLBI) grant opportunity that supports clinician scientists in building a long-term research career focused on sickle cell disease and/or thalassemias.
2. What is the main purpose of this K07 program?
The central aim is career development. The award is intended to provide protected time and resources so a clinician scientist can develop research skills, produce publishable work, and build a foundation for future independent funding in hemoglobinopathy research.
3. Which diseases or research areas does this opportunity focus on?
This opportunity is focused on research related to hemoglobinopathies, specifically sickle cell disease and/or thalassemias.
4. Who is this award intended for?
It is designed for clinician scientists who hold medical or doctoral degrees in clinical fields and who are not yet fully established as independent investigators.
5. What kind of background does NHLBI emphasize for candidates?
The program is especially intended for clinicians who have already demonstrated innovation through patient-focused programs or clinical initiatives in hemoglobinopathies, but who have not previously been on a traditional, formal research track.
6. How is this K07 different from other NHLBI mentored career development awards?
The announcement explicitly states it targets clinician scientists who would not be eligible for other common NHLBI mentored career development awards such as the K23, K01, K08, or K25. It is meant to bring strong, practice-informed clinical innovators into research careers even if their background does not fit the typical profiles of those mechanisms.
7. What is the funding mechanism for this opportunity?
The funding mechanism used is the NIH K07 award.
8. How long can support last under this award?
The award can provide up to four years of support.
9. What types of costs can the award support?
The award provides support for both salary and research-related costs.
10. Is there a minimum effort or time commitment requirement?
Yes. Recipients must commit a minimum of nine person-months per year, which is 75 percent of full-time professional effort, to the award activities.
11. Why is the 75 percent effort requirement important?
The requirement signals that the award is intended to provide protected time so the candidate can focus heavily on career development activities, including developing research skills and generating publishable work.
12. How much total funding did NHLBI plan to commit for this solicitation?
NHLBI planned to commit an estimated total of $2,484,000 in FY2011 to support projects under this solicitation.
13. About how many awards were expected to be made?
NHLBI anticipated making about six awards.
14. What was the projected total spending across the full project periods?
The projected total spending was $9,936,000 across the full four-year project periods for the anticipated awards.
15. What is the maximum budget level (award ceiling) for this opportunity?
The listed award ceiling is $414,000, indicating the maximum budget level per award under the announcement.
16. What is the funding opportunity number for this program?
The funding opportunity number is RFA-HL-10-021.
17. When was this opportunity posted?
It was posted on June 29, 2010.
18. What was the application due date?
The original and current closing date listed for the opportunity was September 14, 2010.
19. When was the opportunity archived?
The archive date was October 15, 2010.
20. Which agency sponsors this grant opportunity?
The sponsoring agency is the National Institutes of Health (NIH), with the National Heart, Lung, and Blood Institute (NHLBI) issuing the announcement.
21. What type of grant is this categorized as?
This opportunity is described as a discretionary grant in the health funding category.
22. What is the CFDA number associated with this program?
The program is associated with CFDA number 93.839, titled Blood Diseases and Resources.
23. Is cost sharing or matching required?
No. The opportunity does not require cost sharing or matching.
24. What types of organizations are eligible to apply?
Eligible applicant organizations include public and state-controlled institutions of higher education, private institutions of higher education, nonprofits with and without 501(c)(3) status (including those other than institutions of higher education), and for-profit organizations other than small businesses.
25. Are institutions serving historically underrepresented populations included in the eligibility information?
Yes. The eligibility information highlights inclusion of institutions such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), and Alaska Native and Native Hawaiian-serving institutions.
26. Does NHLBI encourage contacting staff before applying?
Yes. NHLBI encourages prospective applicants to communicate directly with institute staff to clarify program fit and budget questions before applying.
27. Where was the full announcement hosted?
The full announcement was hosted through the NIH grants guide.
28. Was any contact information mentioned for technical website issues?
Yes. NIH provided standard webmaster contacts for access or linking issues related to the announcement.
Browse more opportunities from the same category: Health
Next opportunity: Boston Harbor Islands National Recreation Area youth program
Previous opportunity: Santa Monica Mountains Fund
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HL 10 021
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HL 10 021) also looked into and applied for these:
| Funding Opportunity |
|---|
| NEI Center Core Grants for Vision Research (P30) Apply for PAR 10 223 Funding Number: PAR 10 223 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| American Indians into Psychology Apply for HHS 2010 IHS INPSY 0001 Funding Number: HHS 2010 IHS INPSY 0001 Agency: Indian Health Service Category: Health Funding Amount: $252,462 |
| Affordable Care Act (ACA) School Based Health Centers Capital Program Apply for HRSA 10 276 Funding Number: HRSA 10 276 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Human Resources Alliance for Africa (HRAA) Apply for 674 10 00047 Funding Number: 674 10 00047 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $50,000,000 |
| FY10 National Umbrella Cooperative Agreement Program (NUCA) Apply for MP MPC 10 006 Funding Number: MP MPC 10 006 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $300,000 |
| National Foundation for the Centers for Disease Control and Prevention Apply for CDC RFA CD10 1001 Funding Number: CDC RFA CD10 1001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,250,000 |
| FY10 The Linkage to Life Program Rebuilding Broken Bridges for Minority Families Impacted by HIV/AIDS. Apply for MP MPC 10 007 Funding Number: MP MPC 10 007 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $475,000 |
| FY10 Partnerships Active in Communities to Achieve Health Equity Apply for MP MPC 10 008 Funding Number: MP MPC 10 008 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $500,000 |
| FY10 Minority Community HIV/AIDS Partnership Preventing Risky Behaviors Among Minority College Students Apply for MP HHP 10 001 Funding Number: MP HHP 10 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $300,000 |
| Malawi Support for Integrated Service Delivery Apply for 674 10 0051 Funding Number: 674 10 0051 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $100,000,000 |
| Partnerships for Next Generation Biodefense Diagnostics (R01) Apply for RFA AI 10 017 Funding Number: RFA AI 10 017 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Mississippi Delta Health Collaborative Apply for CDC RFA DP10 1013 Funding Number: CDC RFA DP10 1013 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Coordination of National Immunization and Respiratory Diseases Activities Apply for CDC RFA IP10 1006 Funding Number: CDC RFA IP10 1006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $275,000 |
| Strengthening Public Health Infrastructure for Improved Health Outcomes Apply for CDC RFA CD10 1011 Funding Number: CDC RFA CD10 1011 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,100,000 |
| Mentored Career Development Award to Promote Faculty Diversity/Re Entry in Biomedical Research (K01) Apply for RFA HL 11 022 Funding Number: RFA HL 11 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| 2011 NIH Directors Pioneer Award Program (DP1) Apply for RFA RM 10 008 Funding Number: RFA RM 10 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Short Term Research Education Program to Increase Diversity in Health Related Research (R25) Apply for RFA HL 11 024 Funding Number: RFA HL 11 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| 2011 NIH Directors New Innovator Award Program (DP2) Apply for RFA RM 10 009 Funding Number: RFA RM 10 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Program to Translate Preparedness and Response Research Findings for Enhanced Response in Health Care Delivery Systems Apply for CDC RFA TP10 001E Funding Number: CDC RFA TP10 001E Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| American Recovery and Reinvestment Act (ARRA) of 2009 Communities Putting Prevention to Work Supplemental Funding to Support Community Mentoring, Technical Assistance and Training Apply for RFA DP09 91202SUPP10 Funding Number: RFA DP09 91202SUPP10 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HL 10 021", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.